Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P Goetz

Showing results (161-170 of 265) with videos related to

Pageof 27
Sort By:
Breast Cancer Research : BCR|May 24, 2023
Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumorsXiaojia Tang, Kevin J Thompson, Krishna R Kalari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistanceMatthew P Goetz, Vera J Suman, Fergus J Couch, et al.
Research Square|March 30, 2023
Clinical Outcomes and Prognostic Factors in Triple-Negative Invasive Lobular Carcinoma of the BreastUtsav Joshi, Pravash Budhathoki, Suman Gaire, et al.
Breast Cancer Research and Treatment|February 26, 2025
The impact of coadministration of venlafaxine, citalopram or gabapentin on the metabolic activation of tamoxifenStephanie L Safgren, Vera J Suman, Roberto A Leon Ferre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2011
Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trialsMatthew P Goetz, Daniel J Schaid, D Lawrence Wickerham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2015
Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice GuidelineCatherine Van Poznak, Mark R Somerfield, Robert C Bast, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 InhibitionKevin Shee, Jason D Wells, Matthew Ung, et al.
Radiology|July 2, 2002
Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablationMatthew R Callstrom, J William Charboneau, Matthew P Goetz, et al.
Cancer Research|February 18, 2021
Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End JoiningQin Zhou, Michelle E Howard, Xinyi Tu, et al.
Pharmacogenetics and Genomics|June 19, 2019
Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancerJames N Ingle, Krishna R Kalari, Yukihide Momozawa, et al.
Pageof 27

Showing results (161-170 of 265) with videos related to

Sort By:
Pageof 27
Breast Cancer Research : BCR|May 24, 2023
Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumorsXiaojia Tang, Kevin J Thompson, Krishna R Kalari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistanceMatthew P Goetz, Vera J Suman, Fergus J Couch, et al.
Research Square|March 30, 2023
Clinical Outcomes and Prognostic Factors in Triple-Negative Invasive Lobular Carcinoma of the BreastUtsav Joshi, Pravash Budhathoki, Suman Gaire, et al.
Breast Cancer Research and Treatment|February 26, 2025
The impact of coadministration of venlafaxine, citalopram or gabapentin on the metabolic activation of tamoxifenStephanie L Safgren, Vera J Suman, Roberto A Leon Ferre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2011
Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trialsMatthew P Goetz, Daniel J Schaid, D Lawrence Wickerham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2015
Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice GuidelineCatherine Van Poznak, Mark R Somerfield, Robert C Bast, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 InhibitionKevin Shee, Jason D Wells, Matthew Ung, et al.
Radiology|July 2, 2002
Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablationMatthew R Callstrom, J William Charboneau, Matthew P Goetz, et al.
Cancer Research|February 18, 2021
Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End JoiningQin Zhou, Michelle E Howard, Xinyi Tu, et al.
Pharmacogenetics and Genomics|June 19, 2019
Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancerJames N Ingle, Krishna R Kalari, Yukihide Momozawa, et al.
Pageof 27